Can SAGA Metals Corp. turn a Rio Tinto castoff into Quebec’s next titanium discovery story? (TSXV: SAGA)
What Olaplex Holdings, Inc.’s $2.06-per-share buyout by Henkel AG & Co. KGaA signals for beauty sector consolidation (NASDAQ: OLPX)
What Cadre Holdings, Inc.’s $10.3m acquisition signals about consolidation in tactical gear markets (NYSE: CDRE)
Rhinebeck Bank taps MANTL for omnichannel account opening as Alkami Technology (ALKT) accelerates post-acquisition integration
Read More 5 minute read Pharma Industry News Will CABOMETYX secure EU approval for advanced neuroendocrine tumors after CHMP’s positive opinion? Ipsen’s CABOMETYX receives EMA's CHMP backing for advanced neuroendocrine tumors; EU approval expected in 2025 following FDA nod. byPallavi MadhirajuJune 24, 2025